Evidence map›Paper›PMID 42668345›Full record

ArticleEuropean journal of drug metabolism and pharmacokinetics2026

Rifampicin Exposures and Clinical Outcomes: An Exploratory Analysis for the Determination of Therapeutic Drug Monitoring Efficacy Targets.

Yuan J Petermann, Bibie Said, Margaretha L Sariko, Yann Thoma, Stellah G Mpagama, Chantal Csajka, Monia Guidi

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of drug metabolism and pharmacokinetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuan J PetermannCentre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 17, CH-1011, Lausanne, Switzerland.
Bibie SaidKibong'oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania.
Margaretha L SarikoKilimanjaro Clinical Research Institute Kilimanjaro, Moshi, United Republic of Tanzania.
Yann ThomaSchool of Engineering and Management Vaud, HES-SO University of Applied Sciences and Arts Western Switzerland, 1401, Yverdon-les-Bains, Switzerland.
Stellah G MpagamaKibong'oto Infectious Diseases Hospital, Sanya Juu, United Republic of Tanzania.
Chantal Csajka *Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 17, CH-1011, Lausanne, Switzerland.
Monia Guidi *Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 17, CH-1011, Lausanne, Switzerland. monia.guidi@chuv.ch.ORCID http://orcid.org/0000-0002-6419-9317

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung IZSTZ0_208544
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.